Terms: = Bone cancer AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Treatment
23 results:
1. Identification of potential biomarkers for aging diagnosis of mesenchymal stem cells derived from the aged donors.
Hao M; Jiang H; Zhao Y; Li C; Jiang J
Stem Cell Res Ther; 2024 Mar; 15(1):87. PubMed ID: 38520027
[TBL] [Abstract] [Full Text] [Related]
2. The impact of surgical resection margins on outcomes for adults with head and neck osteosarcomas: A Canadian sarcoma research and Clinical Collaboration (CanSaRCC) study.
Tzelnick S; Soroka HP; Tasnim N; Gilbert RW; Irish JC; Goldstein DP; Brown D; Gullane P; Chepeha DB; Yao CMKL; Sahovaler A; Witterick IJ; Monteiro E; Davies J; Huang SH; O'Sullivan B; Hahn E; Hosni A; Razak AA; Gupta AA; de Almeida JR
Oral Oncol; 2023 Oct; 145():106495. PubMed ID: 37478572
[TBL] [Abstract] [Full Text] [Related]
3. Successful allogeneic hematopoietic stem cell transplantation for myelodysplastic neoplasms complicated with secondary pulmonary alveolar proteinosis and Behçet's disease harboring gata2 mutation.
Sato Y; Fukatsu M; Suzuki T; Sasajima T; Gunji N; Yoshida S; Asano N; Fukuchi K; Mori H; Takano M; Hayashi K; Takahashi H; Shirado-Harada K; Kimura S; Koyama D; Migita K; Ikezoe T
Int J Hematol; 2023 Nov; 118(5):642-646. PubMed ID: 37084069
[TBL] [Abstract] [Full Text] [Related]
4. Pediatric Germline Predisposition to Myeloid Neoplasms.
Thompson C; Ariagno S; Kohorst MA
Curr Hematol Malig Rep; 2022 Dec; 17(6):266-274. PubMed ID: 36117229
[TBL] [Abstract] [Full Text] [Related]
5. Case report: Successful allogeneic stem cell transplantation in a child with novel gata2 defect associated B-cell acute lymphoblastic leukemia.
Heropolitańska-Pliszka E; Piątosa B; Szmydki-Baran A; Kuczborska K; Miarka-Walczyk K; Pastorczak A; Młynarski W; Sędek Ł; Szczepański T; Ussowicz M
Front Immunol; 2022; 13():928529. PubMed ID: 35983050
[TBL] [Abstract] [Full Text] [Related]
6. GATA 2 Deficiency: Focus on Immune System Impairment.
Fabozzi F; Mastronuzzi A; Ceglie G; Masetti R; Leardini D
Front Immunol; 2022; 13():865773. PubMed ID: 35769478
[TBL] [Abstract] [Full Text] [Related]
7. A Nationwide Study of gata2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCT.
Jørgensen SF; Buechner J; Myhre AE; Galteland E; Spetalen S; Kulseth MA; Sorte HS; Holla ØL; Lundman E; Alme C; Heier I; Flægstad T; Fløisand Y; Benneche A; Fevang B; Aukrust P; Stray-Pedersen A; Gedde-Dahl T; Nordøy I
J Clin Immunol; 2022 Feb; 42(2):404-420. PubMed ID: 34893945
[TBL] [Abstract] [Full Text] [Related]
8. Hematopoietic stem cell transplantation in children and adolescents with gata2-related myelodysplastic syndrome.
Bortnick R; Wlodarski M; de Haas V; De Moerloose B; Dworzak M; Hasle H; Masetti R; Starý J; Turkiewicz D; Ussowicz M; Kozyra E; Albert M; Bader P; Bordon V; Cario G; Beier R; Schulte J; Bresters D; Müller I; Pichler H; Sedlacek P; Sauer MG; Zecca M; Göhring G; Yoshimi A; Noellke P; Erlacher M; Locatelli F; Niemeyer CM; Strahm B;
Bone Marrow Transplant; 2021 Nov; 56(11):2732-2741. PubMed ID: 34244664
[TBL] [Abstract] [Full Text] [Related]
9. Therapeutic options for CTLA-4 insufficiency.
Egg D; Rump IC; Mitsuiki N; Rojas-Restrepo J; Maccari ME; Schwab C; Gabrysch A; Warnatz K; Goldacker S; Patiño V; Wolff D; Okada S; Hayakawa S; Shikama Y; Kanda K; Imai K; Sotomatsu M; Kuwashima M; Kamiya T; Morio T; Matsumoto K; Mori T; Yoshimoto Y; Dybedal I; Kanariou M; Kucuk ZY; Chapdelaine H; Petruzelkova L; Lorenz HM; Sullivan KE; Heimall J; Moutschen M; Litzman J; Recher M; Albert MH; Hauck F; Seneviratne S; Pachlopnik Schmid J; Kolios A; Unglik G; Klemann C; Snapper S; Giulino-Roth L; Svaton M; Platt CD; Hambleton S; Neth O; Gosse G; Reinsch S; Holzinger D; Kim YJ; Bakhtiar S; Atschekzei F; Schmidt R; Sogkas G; Chandrakasan S; Rae W; Derfalvi B; Marquart HV; Ozen A; Kiykim A; Karakoc-Aydiner E; Králíčková P; de Bree G; Kiritsi D; Seidel MG; Kobbe R; Dantzer J; Alsina L; Armangue T; Lougaris V; Agyeman P; Nyström S; Buchbinder D; Arkwright PD; Grimbacher B
J Allergy Clin Immunol; 2022 Feb; 149(2):736-746. PubMed ID: 34111452
[TBL] [Abstract] [Full Text] [Related]
10. Hematopoietic Cell Transplantation and Outcomes Related to Human Papillomavirus Disease in gata2 Deficiency.
Parta M; Cole K; Avila D; Duncan L; Baird K; Schuver BB; Wilder J; Palmer C; Daub J; Hsu AP; Zerbe CS; Marciano BE; Cuellar-Rodriguez JM; Bauer TR; Nason M; Calvo KR; Merideth M; Stratton P; DeCherney A; Shah NN; Holland SM; Hickstein DD
Transplant Cell Ther; 2021 May; 27(5):435.e1-435.e11. PubMed ID: 33965189
[TBL] [Abstract] [Full Text] [Related]
11. Comparison of Outcomes of Myeloablative Allogeneic Stem Cell Transplantation for Pediatric Patients with bone Marrow Failure, Myelodysplastic Syndrome and Acute Myeloid Leukemia with and without Germline gata2 Mutations.
Hofmann I; Avagyan S; Stetson A; Guo D; Al-Sayegh H; London WB; Lehmann L
Biol Blood Marrow Transplant; 2020 Jun; 26(6):1124-1130. PubMed ID: 32088370
[TBL] [Abstract] [Full Text] [Related]
12. Decoding bone Marrow Fibrosis in Myelodysplastic Syndromes.
Melody M; Al Ali N; Zhang L; Ramadan H; Padron E; Sallman D; Sweet K; Lancet J; List A; Bennett JM; Komrokji R
Clin Lymphoma Myeloma Leuk; 2020 May; 20(5):324-328. PubMed ID: 32044274
[TBL] [Abstract] [Full Text] [Related]
13. Secondary acquisition of BCR-ABL1 fusion in de novo gata2-MECOM positive acute myeloid leukemia with subsequent emergence of a rare KMT2A-ASXL2 fusion.
Blackburn PR; Huang L; Dalovisio A; Pitel BA; Chen D; Oliveira JL; Wood AJ; Smadbeck JB; Johnson SH; Vasmatzis G; Haferlach C; Greipp PT; Hoppman NL; Ketterling RP; Baughn LB; Peterson JF
Cancer Genet; 2020 Feb; 241():67-71. PubMed ID: 31902694
[TBL] [Abstract] [Full Text] [Related]
14. gata2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner.
Bogaert DJ; Laureys G; Naesens L; Mazure D; De Bruyne M; Hsu AP; Bordon V; Wouters E; Tavernier SJ; Lambrecht BN; De Baere E; Haerynck F; Kerre T
Br J Haematol; 2020 Mar; 188(5):768-773. PubMed ID: 31710708
[TBL] [Abstract] [Full Text] [Related]
15. Natural history of gata2 deficiency in a survey of 79 French and Belgian patients.
Donadieu J; Lamant M; Fieschi C; de Fontbrune FS; Caye A; Ouachee M; Beaupain B; Bustamante J; Poirel HA; Isidor B; Van Den Neste E; Neel A; Nimubona S; Toutain F; Barlogis V; Schleinitz N; Leblanc T; Rohrlich P; Suarez F; Ranta D; Chahla WA; Bruno B; Terriou L; Francois S; Lioure B; Ahle G; Bachelerie F; Preudhomme C; Delabesse E; Cave H; Bellanné-Chantelot C; Pasquet M;
Haematologica; 2018 Aug; 103(8):1278-1287. PubMed ID: 29724903
[TBL] [Abstract] [Full Text] [Related]
16. The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.
Bolouri H; Farrar JE; Triche T; Ries RE; Lim EL; Alonzo TA; Ma Y; Moore R; Mungall AJ; Marra MA; Zhang J; Ma X; Liu Y; Liu Y; Auvil JMG; Davidsen TM; Gesuwan P; Hermida LC; Salhia B; Capone S; Ramsingh G; Zwaan CM; Noort S; Piccolo SR; Kolb EA; Gamis AS; Smith MA; Gerhard DS; Meshinchi S
Nat Med; 2018 Jan; 24(1):103-112. PubMed ID: 29227476
[TBL] [Abstract] [Full Text] [Related]
17. Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for treatment of Marrow Failure Disorders.
Burroughs LM; Shimamura A; Talano JA; Domm JA; Baker KK; Delaney C; Frangoul H; Margolis DA; Baker KS; Nemecek ER; Geddis AE; Sandmaier BM; Deeg HJ; Storb R; Woolfrey AE
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1669-1677. PubMed ID: 28602958
[TBL] [Abstract] [Full Text] [Related]
18. The Influence of Histologic Subtype in Predicting Survival of Lung cancer Patients With Spinal Metastases.
Kumar N; Tan KA; Tan JH; Zaw AS; Hey HWD; Ruiz J; Stone E
Clin Spine Surg; 2018 Feb; 31(1):E1-E7. PubMed ID: 27875414
[TBL] [Abstract] [Full Text] [Related]
19. Acute lymphoblastic leukemia in a patient with MonoMAC syndrome/gata2 haploinsufficiency.
Koegel AK; Hofmann I; Moffitt K; Degar B; Duncan C; Tubman VN
Pediatr Blood Cancer; 2016 Oct; 63(10):1844-7. PubMed ID: 27232273
[TBL] [Abstract] [Full Text] [Related]
20. Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).
DiNardo CD; Bannon SA; Routbort M; Franklin A; Mork M; Armanios M; Mace EM; Orange JS; Jeff-Eke M; Churpek JE; Takahashi K; Jorgensen JL; Garcia-Manero G; Kornblau S; Bertuch A; Cheung H; Bhalla K; Futreal A; Godley LA; Patel KP
Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):417-428.e2. PubMed ID: 27210295
[TBL] [Abstract] [Full Text] [Related]
[Next]
